drugset / Trial / NCT01546142

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

NCT01546142

Phase 3 Completed 516 enrolled Kythera Biopharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the safety and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).

Timeline

Start
2012-03
Primary completion
2013-05
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Deoxycholic Acid Small molecule 2 unknown

Indications

No indication recorded.